DJIA 18,266.75 -18.99 -0.10%
NASDAQ 5,096.54 5.74 0.11%
S&P 500 2,129.35 -1.47 -0.07%
market minute promo

Illumina (NASDAQ: ILMN)

204.90 1.78 (0.88%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ILMN $204.90 0.88%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $203.40
Previous Close $203.12
Daily Range $203.00 - $204.83
52-Week Range $145.12 - $213.33
Market Cap $29.5B
P/E Ratio 70.28
Dividend (Yield) $0.00 (0.0%)
Volume 210,945
Average Daily Volume 1,333,628
Current FY EPS $3.43




Drug Makers

Illumina (ILMN) Description

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Website:

News & Commentary

Could This Be Healthcare's $158 Billion Black Swan Event?

This unlikely event is becoming increasingly more likely -- and the impact would be enormous.

Why CorMedix (CRMD) Could Be Positioned for a Slump - Tale of the Tape

Weakness Seen in Achillion Pharmaceuticals (ACHN): Stock Tumbles 15.3% - Tale of the Tape

Benzinga's Top Upgrades

Morgan Stanley Upgrades Illumina To Overweight

Insider Trading Alert - ILMN, CMPR And UTEK Traded By Insiders

Genomic Health's Loss Lingers, Profits Expected in 4Q15 - Analyst Blog

Achillion Pharmaceuticals (ACHN) Jumps: Stock Up 15.3% - Tale of the Tape

Insider Trading Alert - GSIG, ILMN And ORM Traded By Insiders

3 Ways Personalized Medicine Could Completely Transform Your Life

The one-size-fits-all doctor-patient relationship that's existed for decades is slowly dying. Instead, an array of new personalized interactions, along with diagnostics, devices, and therapies, are taking its place.

See More ILMN News...

ILMN's Top Competitors

ILMN $204.90 (0.88%)
Current stock: ILMN
QGEN $25.08 (0.12%)
Current stock: QGEN
TMO $133.27 (0.32%)
Current stock: TMO
WAT $134.01 (0.13%)
Current stock: WAT